Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Otonomy stock
Learn how to easily invest in Otonomy stock.
Otonomy Inc is a biotechnology business based in the US. Otonomy shares (OTIC) are listed on the NASDAQ and all prices are listed in US Dollars. Otonomy employs 51 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Otonomy
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – OTIC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Otonomy stock price (NASDAQ: OTIC)Use our graph to track the performance of OTIC stocks over time.
Otonomy shares at a glance
|Latest market close||$0.30|
|52-week range||$0.24 - $2.59|
|50-day moving average||$0.55|
|200-day moving average||$1.72|
|Wall St. target price||$6.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.78|
Buy Otonomy shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Otonomy stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Otonomy price performance over time
|1 week (2022-09-26)||5.92%|
|1 month (2022-09-02)||-16.03%|
|3 months (2022-07-01)||-85.75%|
|6 months (2022-04-01)||-87.50%|
|1 year (2021-10-01)||-83.52%|
|2 years (2020-10-02)||-93.36%|
|3 years (2019-10-03)||2.18|
|5 years (2017-10-03)||3.5|
|Gross profit TTM||$-245,000|
|Return on assets TTM||-34.62%|
|Return on equity TTM||-96.77%|
|Market capitalisation||$16.9 million|
TTM: trailing 12 months
Otonomy share dividends
We're not expecting Otonomy to pay a dividend over the next 12 months.
Otonomy share price volatility
Over the last 12 months, Otonomy's shares have ranged in value from as little as $0.24 up to $2.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Otonomy's is 1.4778. This would suggest that Otonomy's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Otonomy, Inc. , a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Frequently asked questionsWhat percentage of Otonomy is owned by insiders or institutions?
Currently 2.049% of Otonomy shares are held by insiders and 68.997% by institutions. How many people work for Otonomy?
Latest data suggests 51 work at Otonomy. When does the fiscal year end for Otonomy?
Otonomy's fiscal year ends in December. Where is Otonomy based?
Otonomy's address is: 4796 Executive Drive, San Diego, CA, United States, 92121 What is Otonomy's ISIN number?
Otonomy's international securities identification number is: US68906L1052 What is Otonomy's CUSIP number?
Otonomy's Committee on Uniform Securities Identification Procedures number is: 68906L105
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert